Chemours Co (CC)

Pretax margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Earnings before tax but after interest (EBT) (ttm) US$ in thousands -308,000 -306,000 -30,000 634,000 741,000 1,112,000 1,044,000 857,000 678,000 399,000 228,000 204,000 180,000 -297,000 -266,000 -153,000 -123,000 513,000 691,000 880,000
Revenue (ttm) US$ in thousands 5,881,000 5,818,000 6,130,000 6,410,000 6,639,000 6,872,000 6,744,000 6,477,000 6,141,000 5,876,000 5,441,000 4,873,000 4,737,000 4,824,000 4,981,000 5,297,000 5,371,000 5,668,000 5,912,000 6,286,000
Pretax margin -5.24% -5.26% -0.49% 9.89% 11.16% 16.18% 15.48% 13.23% 11.04% 6.79% 4.19% 4.19% 3.80% -6.16% -5.34% -2.89% -2.29% 9.05% 11.69% 14.00%

December 31, 2023 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $-308,000K ÷ $5,881,000K
= -5.24%

The pretax margin of Chemours Co has experienced fluctuations over the past few years. In the most recent quarter, the pretax margin was -5.24%, indicating that the company incurred a pre-tax loss relative to its revenue. This decline follows a similar trend from the previous quarter where the pretax margin was -5.26%.

In contrast, in the quarter ended March 31, 2023, the pretax margin improved significantly to 9.89%, showing that the company generated a healthy pre-tax profit relative to its revenue. This positive trend was also seen in the quarters ending December 31, 2022, and September 30, 2022, where the pretax margins were 11.16% and 16.18%, respectively.

Overall, the pretax margin of Chemours Co seems to fluctuate, indicating varying levels of profitability and efficiency in managing its costs and generating income. It is important for the company to closely monitor and analyze its financial performance to address any negative trends and capitalize on periods of positive profitability.